Compliance With Standard Care vs Ready to Eat Meals Prior to Bariatric Surgery
1 other identifier
interventional
140
1 country
2
Brief Summary
Currently, a ketosis-inducing programme, usually a liquid meal replacement, is the standard of care for pre-operative dietary management. However, compliance with liduiqd meal replacement is challenging primarily due to individual taste preferences, limited variety, having to take a liquid diet, lifestyle factors, and other obstacles. Therefore, there is a need for RTE meals to enhance patient satisfaction and compliance, ultimately resulting in improved pre-operative weight loss outcomes. Hence, this RCT study aims to determine whether Very Low Calorie Diet Ready-to-eat (VLCD RTE) meals would lead to greater compliance as measured by blood ketones and meal logging via Nutritionist Buddy app (nBuddy App) compared to standard care liquid meal replacement (Optifast) prior to bariatric surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2024
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 5, 2024
CompletedFirst Posted
Study publicly available on registry
June 14, 2024
CompletedStudy Start
First participant enrolled
July 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2026
September 12, 2025
September 1, 2025
2.2 years
June 5, 2024
September 5, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Compliance rate of the RTE meals
The compliance rate is assessed via food logging in the nutritionist buddy keto app
Daily for intervention period of 28 days
Blood Ketones Measurement
Fasting blood ketone measurements measured at study visit
1st week, 2nd week, 3rd week, 4th week, surgery day
Secondary Outcomes (2)
Satisfaction of the RTE meals
3rd week and surgery day
Weight Change
1st week, 2nd week, 3rd week, 4th week, surgery day
Study Arms (2)
Very Low Calorie Diet Ready-to-eat (VLCD RTE) meals
EXPERIMENTALParticipants (n=70) in the VLCD RTE meals group will be advised to follow a calorie-restricted healthy ketogenic diet , consuming a maximum of 800 calories and 50g net carbohydrate intake daily. Participants will be provided with VLCD RTE meals for lunch and dinner for 4 weeks and advised on a healthy keto breakfast. The participants will be expected to self-monitor their weight, physical activity and diet logs via the nutritionist buddy keto app. There will be in app virtual reminders (automated and by dietitians via the chat function) sent via the nutritionist buddy keto application for the 1 month for participants to log in their weight and meals.
Liquid Meal Replacement
ACTIVE COMPARATORParticipants (n=70) in the liquid meal replacement group will be advised to follow very low-calorie diet, with a maximum of 800 calories and 50g net carbohydrate intake daily. Participants will be provided with a liquid meal replacement for breakfast, lunch, and dinner for 4 weeks. Additionally, patients are to prepare 1 serving of non-starchy vegetables are to be included for lunch and dinner. The participants will be expected to self-monitor their weight, physical activity and diet logs via the nutritionist buddy keto app. There will be in app virtual reminders (automated and by dietitians via the chat function) sent via the nutritionist buddy keto application for the 1 month for participants to log in their weight and meals.
Interventions
Participants will be provided with VLCD RTE meals for lunch and dinner for 4 weeks and advised on a healthy ketogenic breakfast. Participant will be expected to adhere to VLCD regimen containing 800 calories per day or fewer and keep within 50g net carbohydrates a day.
Participants will be provided with liquid meal replacement for breakfast, lunch, and dinner for 4 weeks. Additionally, patients are to prepare 1 serving of non-starchy vegetables are to be included for lunch and dinner. Participant will be expected to adhere to VLCD regimen containing 800 calories per day or fewer and keep within 50g net carbohydrates a day.
Eligibility Criteria
You may qualify if:
- Adults aged 21 to 65 years old
- Scheduled for bariatric surgery at least 1 month prior
- BMI ≥ 27.5 kg/m2 (with type 2 diabetes mellitus or metabolic syndrome)
- Owns a smart phone with data plan
- English speaking
You may not qualify if:
- Cognitive impairment.
- Hypothyroidism
- Chronic kidney disease
- Hypothyroidism
- Depression with ongoing psychology follow up
- Type 1 diabetes
- Liver Cirrhosis
- Pregnancy
- Heart Failure
- Active cancer or in remission for less than 5 years
- Vegetarian
- Observing the fast during the month of Ramadan
- Undergoing treatment with anti obesity medications (eg: Phentermine/Orlistat/Contrave/GLP-1 analogues etc)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- National University Hospital, Singaporelead
- Alexandra Hospitalcollaborator
Study Sites (2)
Alexandra Hospital
Singapore, Singapore
National University Hospital
Singapore, Singapore
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Melissa Tay
National University Hospital, Singapore
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- It is not feasible to apply blinding to the study design due to the nature of the intervention.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 5, 2024
First Posted
June 14, 2024
Study Start
July 1, 2024
Primary Completion (Estimated)
September 1, 2026
Study Completion (Estimated)
September 1, 2026
Last Updated
September 12, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will remain confidential and only accessible via lock and keys by the researchers.